Autosomal dominant calpainopathy due to heterozygous CAPN3 C.643_663del21. Issue 4 (30th September 2017)

• Record Type: Journal Article
• Authors: Martinez‐Thompson, Jennifer M.; Niu, Zhiyv; Tracy, Jennifer A.; Moore, Steven A.; Swenson, Andrea; Wieben, Eric D.; Milone, Margherita
• Is Part Of: Muscle & nerve. Volume 57:Issue 4(2018)
• Page Start: 679
• Page End: 683
• Publication Date: 2017-09-30
• Subjects: autosomal dominant myopathy -- axial myopathy -- CAPN3 -- limb‐girdle muscular dystrophy; Neuromuscular diseases -- Periodicals; Muscles -- Periodicals; Nerves -- Periodicals; 616.74
• DOI: 10.1002/mus.25970
• Languages: English
• ISSNs: 0148-639X

Abstract

ABSTRACT: Introduction: A calpain‐3 ( CAPN3 ) gene heterozygous deletion (c.643_663del21) was recently linked to autosomal dominant (AD) limb‐girdle muscular dystrophy. However, the possibility of digenic disease was raised. We describe 3 families with AD calpainopathy carrying this isolated mutation. Methods: Probands heterozygous for CAPN3 c.643_663del21 were identified by targeted next generation or whole exome sequencing. Clinical findings were collected for probands and families. Calpain‐3 muscle Western blots were performed in 3 unrelated individuals. Results: Probands reported variable weakness in their 40s or 50s, with myalgia, back pain, or hyperlordosis. Pelvic girdle muscles were affected with adductor and hamstring sparing. Creatine kinase was normal to 1, 800 U/L, independent of weakness severity. Imaging demonstrated lumbar paraspinal muscle atrophy. Electromyographic findings and muscle biopsies were normal to mildly myopathic. Muscle calpain‐3 expression was reduced. Discussion: This study provides further evidence for AD calpainopathy associated with CAPN3 c.643_663del21. No pathogenic variants in other genes known to cause myopathy were detected. Muscle Nerve 57 : 679–683, 2018